Syenza’s webinar on AI governance in HTA drew 71% of participants who had not yet used AI in their work. The session covered the paper’s governance checklist, the in-house Navigator tool, and a live rapid HTA of rituximab in lupus. #SyenzaNews #HTA #AIinHealth #MarketAccess
